Dr. Helena Linardou has been actively involved in preclinical and clinical research since her degree in Medicine from University of Athens in 1989. She completed a PhD in London (ICRF, Hammersmith Campus, Imperial College of Technology & Medicine) related to targeted cancer therapy, utilising genetically engineered macromolecules. She was fully trained in medical oncology partly in Greece and mainly in the UK, and is a qualified medical oncologist, Board Certified in Greece and ESMO Board Certified since 2000. Since then she has maintained a strong involvement in translational medicine, specifically oriented towards biomarker-driven patient stratification. She has gained extensive experie...